GentiBio Launches with $20M Seed Funding
GentiBio Launches with $20M Seed Funding Back to HomeBOSTON, MA, GentiBio has closed a $20 million seed funding led by OrbiMed, Novartis Venture Fund and RA Capital Management. "This partnership with GentiBio is an important step forward in identifying and improving novel treatments for autoimmune diseases-a key goal of the Benaroya Research Institute. As one of the nation's top five pediatric research centers, Seattle Children's Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Join Seattle Children's bold initiative - It Starts With Yes: The Campaign for Seattle Children's - to transform children's health for generations to come. An internationally recognized medical research institute, BRI accelerates discovery through laboratory breakthroughs in immunology that are translated to clinical therapies.